Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-13, Stock:PFE, The news for the past five days is as follows:
2019-11-06: NEWS1: Pfizer Beats Earnings as Weekly Chart Stays Positive.
2019-11-07: NEWS1: David Carlson Trims Charles Schwab, Exits Verizon.NEWS2: Aerie (AERI) Q3 Loss Wider, Sales Beat, Guidance Slashed.NEWS3: [video]Pfizer's Long-Term Outlook Is Murky, Says UBS on Lowering Price Target.
2019-11-08: NEWS1: Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial.NEWS2: Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial.NEWS3: EMD Serono and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial.NEWS4: Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial.
2019-11-11: NEWS1: Pfizer-Merck KGaA's Bavencio Fails in 2nd Gastric Cancer Study.NEWS2: Walgreens' stock surge providing a 25-point cushion to the Dow's price.
2019-11-12: NEWS1: Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination.NEWS2: Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination.NEWS3: Pfizer Announces Results of Phase 3 Study for XELJANZ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting.

Answer: Decrease